Virtual Library

Start Your Search

  • WCLC 2013

    15th World Conference on Lung Cancer

    Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.

    Presentation Date(s):  
    • October 27 - 30, 2013
    • Total Presentations: 2517

Filter Results:

Show Only Available Presentations

  • +

    MO03 - Thymic Malignancies

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 11
    • Moderators:F. Detterbeck
    • Coordinates: 10/28/2013, 10:30 - 12:00, Bayside Gallery B, Level 1
  • +

    E03 - Chemotherapy for NSCLC

    • Type: Educational Session
    • Track: Medical Oncology
    • Presentations: 5
    • Moderators:R. Pirker
    • Coordinates: 10/28/2013, 14:00 - 15:30, Bayside Auditorium A, Level 1
  • +

    MO07 - NSCLC - Targeted Therapies II

    • Type: Mini Oral Abstract Session
    • Track: Medical Oncology
    • Presentations: 14
    • Moderators:T. John
    • Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium B, Level 1
    • +

      MO07.07 - Combined pan-ERBB and ALK/ROS1/MET inhibition with dacomitinib and crizotinib in advanced non-small cell lung cancer (NSCLC): update of a phase I trial

      16:50 - 16:55  |  Author(s): G. Giaccone

      • Abstract
      • Presentation
      • Slides

      Loading...

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

      IASLC Members: To view this content or have the option to purchase this event, click here to login.
      Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.

  • +

    O08 - Preclinical Therapeutic Models I

    • Type: Oral Abstract Session
    • Track: Biology
    • Presentations: 7
    • Moderators:C. Mascaux
    • Coordinates: 10/28/2013, 16:15 - 17:45, Bayside Auditorium A, Level 1
  • +

    PL03 - Presidential Symposium Including Top Rated Abstracts

    • Type: Plenary Session
    • Track:
    • Presentations: 8
    • Moderators:M. Boyer
    • Coordinates: 10/29/2013, 08:15 - 09:45, Plenary Hall, Ground Level
    • +

      PL03.07 - Treatment with Therapies Matched to Oncogenic Drivers Improves Survival in Patients with Lung Cancers: Results from The Lung Cancer Mutation Consortium (LCMC)

      09:21 - 09:33  |  Author(s): M.G. Kris

      • Abstract

      Loading...

  • +

    Best of Posters - IASLC Selection - Part 1

    • Type: Exhibit Showcase Session
    • Track:
    • Presentations: 4
    • Coordinates: 10/29/2013, 09:55 - 10:25, Exhibit Hall, Ground Level
    • +

      P1.11-032 - Results with dacomitinib (PF-00299804), an irreversible pan-HER tyrosine kinase inhibitor, in a phase II cohort of patients with HER2-mutant or amplified lung cancers

      10:00 - 10:05  |  Author(s): M.G. Kris

      • Abstract

      Loading...